Cryolife Inc  

(Public, NYSE:CRY)   Watch this stock  
Find more results for Ronald W. Benson´┐Ż
13.91
+0.16 (1.16%)
Real-time:   9:30AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 13.87 - 14.00
52 week 8.94 - 14.18
Open 13.87
Vol / Avg. 0.00/262,052.00
Mkt cap 518.95M
P/E 61.33
Div/yield 0.03/0.86
EPS 0.23
Shares 34.11M
Beta 1.12
Inst. own 59%
Jul 26, 2016
Q2 2016 CryoLife Inc Earnings Call - Webcast
Jul 25, 2016
Q2 2016 CryoLife Inc Earnings Release
May 19, 2016
CryoLife Inc Annual Shareholders Meeting (Estimated)
May 18, 2016
CryoLife Inc Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 5.91% 2.75%
Operating margin 15.47% 3.67%
EBITD margin - 7.69%
Return on average assets 4.26% 2.24%
Return on average equity 5.72% 2.58%
Employees 540 -
CDP Score - -

Address

1655 Roberts Blvd NW
KENNESAW, GA 30144-3632
United States - Map
+1-770-4193355 (Phone)
+1-770-4260031 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CryoLife, Inc. (CryoLife) is engaged in medical device manufacturing and distribution, and in the processing and distribution of implantable human tissues for cardiac and vascular surgeries. The Company operates in two segments: Medical Devices and Preservation Services. The Medical Devices segment sells BioGlue, BioFoam, PerClot, CardioGenesis cardiac laser therapy, Hemodialysis Reliable Outflow (HeRO) Graft, and ProCol Vascular Bioprosthesis (ProCol). The Preservation Services segment preserves cardiac and vascular tissues. The Company's surgical sealants and hemostats include BioGlue Surgical Adhesive (BioGlue), BioFoam Surgical Matrix (BioFoam), and PerClot, an absorbable powdered hemostat, which the Company distributes internationally for Starch Medical, Inc. (SMI). Its CardioGenesis cardiac laser therapy product line includes a laser console system and single-use, fiber-optic handpieces.

Officers and directors

James Patrick Mackin Chairman of the Board, President, Chief Executive Officer
Age: 49
Bio & Compensation  - Reuters
D. Ashley Lee CPA Chief Financial Officer, Chief Operating Officer, Executive Vice President
Age: 51
Bio & Compensation  - Reuters
John Davis Senior Vice President - Global Sales and Marketing
Age: 51
Bio & Compensation  - Reuters
William Matthews Senior Vice President - Operations, Quality, and Regulatory
Age: 61
Bio & Compensation  - Reuters
Amy D. Horton CPA Chief Accounting Officer
Age: 44
Bio & Compensation  - Reuters
Jean F. Holloway Chief Compliance Officer, Vice President, General Counsel, Secretary
Age: 58
Bio & Compensation  - Reuters
Scott B. Capps Vice President - Clinical Research
Age: 49
Bio & Compensation  - Reuters
David C. Gale Ph.D. Vice President - Research & Development
Age: 48
Bio & Compensation  - Reuters
Jon W. Salveson Director
Age: 50
Bio & Compensation  - Reuters
Thomas F. Ackerman Independent Director
Age: 60
Bio & Compensation  - Reuters